134 related articles for article (PubMed ID: 11549315)
1. Characterization of the homeodomain gene EMX2: sequence conservation, expression analysis, and a search for mutations in endometrial cancers.
Noonan FC; Mutch DG; Ann Mallon M; Goodfellow PJ
Genomics; 2001 Aug; 76(1-3):37-44. PubMed ID: 11549315
[TBL] [Abstract][Full Text] [Related]
2. EMX2 is downregulated in endometrial cancer and correlated with tumor progression.
Qiu H; Yan Q; Luo X; Zhang H; Bao W; Wan X
Int J Gynecol Pathol; 2013 Mar; 32(2):193-8. PubMed ID: 23370654
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the E-cadherin gene in human gynecologic cancers.
Risinger JI; Berchuck A; Kohler MF; Boyd J
Nat Genet; 1994 May; 7(1):98-102. PubMed ID: 8075649
[TBL] [Abstract][Full Text] [Related]
5. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
[TBL] [Abstract][Full Text] [Related]
6. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
9. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
10. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
11. Antisense transcripts at the EMX2 locus in human and mouse.
Noonan FC; Goodfellow PJ; Staloch LJ; Mutch DG; Simon TC
Genomics; 2003 Jan; 81(1):58-66. PubMed ID: 12573261
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.
Li Y; Chen Z
Cancer Lett; 2004 Jun; 209(1):75-85. PubMed ID: 15145523
[TBL] [Abstract][Full Text] [Related]
13. PHTF, a novel atypical homeobox gene on chromosome 1p13, is evolutionarily conserved.
Raich N; Mattei MG; Romeo PH; Beaupain D
Genomics; 1999 Jul; 59(1):108-9. PubMed ID: 10395808
[No Abstract] [Full Text] [Related]
14. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression.
Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW
Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977
[TBL] [Abstract][Full Text] [Related]
15. Expression of homeobox genes in cervical cancer.
Li H; Huang CJ; Choo KB
Gynecol Oncol; 2002 Feb; 84(2):216-21. PubMed ID: 11812077
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomics of the Hlx homeobox gene and protein: conservation of structure and expression from fish to mammals.
Bates MD; Wells JM; Venkatesh B
Gene; 2005 Jun; 352():45-56. PubMed ID: 15935575
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
Moreno-Bueno G; Fernandez-Marcos PJ; Collado M; Tendero MJ; Rodriguez-Pinilla SM; Garcia-Cao I; Hardisson D; Diaz-Meco MT; Moscat J; Serrano M; Palacios J
Cancer Res; 2007 Mar; 67(5):1927-34. PubMed ID: 17332319
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma.
Pavelić J; Radaković B; Pavelić K
Gynecol Oncol; 2007 Jun; 105(3):727-35. PubMed ID: 17399767
[TBL] [Abstract][Full Text] [Related]
19. Biologic targets for therapeutic intervention in endometrioid endometrial adenocarcinoma and malignant mixed müllerian tumors.
Rice LW; Stone RL; Xu M; Galgano M; Stoler MH; Everett EN; Jazaeri AA
Am J Obstet Gynecol; 2006 Apr; 194(4):1119-26; discussion 1126-8. PubMed ID: 16580307
[TBL] [Abstract][Full Text] [Related]
20. The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer.
Mollenhauer J; Müller H; Kollender G; Lyer S; Diedrichs L; Helmke B; Holmskov U; Ligtenberg T; Herbertz S; Krebs I; Madsen J; Bikker F; Schmitt L; Wiemann S; Scheurlen W; Otto HF; von Deimling A; Poustka A
Genes Chromosomes Cancer; 2002 Nov; 35(3):242-55. PubMed ID: 12353266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
